Alma Fulurija

Title: Alma Fulurija: Innovator in Medical Science

Introduction

Alma Fulurija is a prominent inventor based in Zürich-Schlieren, Switzerland. She has made significant contributions to the fields of medicine, public health, immunology, molecular biology, and virology. With a total of two patents to her name, her work focuses on innovative solutions for health-related challenges.

Latest Patents

Alma's latest patents include the development of gastric inhibitory polypeptide (GIP) antigen arrays and their uses. This invention provides a composition comprising a virus-like particle (VLP) and at least one antigen, specifically a GIP protein or a GIP fragment linked to the VLP. The invention outlines methods for producing this composition, which is particularly useful in the production of vaccines aimed at preventing and treating obesity. The compositions are designed to induce efficient immune responses, particularly antibody responses, and are effective in promoting self-specific immune responses.

Career Highlights

Alma Fulurija is associated with Cytos Biotechnology AG, where she continues to advance her research and innovations. Her work is pivotal in developing immunogens that can help in the prevention and treatment of obesity and other related conditions.

Collaborations

Alma has collaborated with notable colleagues, including Martin F Bachmann and Philippe Paul Saudan, contributing to the advancement of her research and the impact of her inventions.

Conclusion

Alma Fulurija stands out as an influential inventor in the medical field, with her innovative patents addressing critical health issues. Her contributions are paving the way for future advancements in immunology and public health.